(Q30664468)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23995268%20AND%20SRC:MED&resulttype=core&format=json

8 March 2020

title

Evaluation of various static and dynamic modeling methods to predict clinical CYP3A induction using in vitro CYP3A4 mRNA induction data (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23995268%20AND%20SRC:MED&resulttype=core&format=json

8 March 2020

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23995268%20AND%20SRC:MED&resulttype=core&format=json

8 March 2020

author name string

H J Einolf

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23995268%20AND%20SRC:MED&resulttype=core&format=json

8 March 2020

L Chen

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23995268%20AND%20SRC:MED&resulttype=core&format=json

8 March 2020

O A Fahmi

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23995268%20AND%20SRC:MED&resulttype=core&format=json

8 March 2020

C R Gibson

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23995268%20AND%20SRC:MED&resulttype=core&format=json

8 March 2020

R S Obach

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23995268%20AND%20SRC:MED&resulttype=core&format=json

8 March 2020

J Silva

7

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23995268%20AND%20SRC:MED&resulttype=core&format=json

8 March 2020

M W Sinz

8

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23995268%20AND%20SRC:MED&resulttype=core&format=json

8 March 2020

J D Unadkat

9

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23995268%20AND%20SRC:MED&resulttype=core&format=json

8 March 2020

L Zhang

10

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23995268%20AND%20SRC:MED&resulttype=core&format=json

8 March 2020

P Zhao

11

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23995268%20AND%20SRC:MED&resulttype=core&format=json

8 March 2020

language of work or name

English

0 references

publication date

29 August 2013

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23995268%20AND%20SRC:MED&resulttype=core&format=json

Clinical Pharmacology & Therapeutics

8 March 2020

published in

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23995268%20AND%20SRC:MED&resulttype=core&format=json

8 March 2020

volume

95

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23995268%20AND%20SRC:MED&resulttype=core&format=json

8 March 2020

issue

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23995268%20AND%20SRC:MED&resulttype=core&format=json

8 March 2020

page(s)

179-188

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23995268%20AND%20SRC:MED&resulttype=core&format=json

Current industrial practices in assessing CYP450 enzyme induction: preclinical and clinical

8 March 2020

cites work

1 reference

https://api.crossref.org/works/10.1038%2FCLPT.2013.170

In vitro and in vivo induction of cytochrome p450: a survey of the current practices and recommendations: a pharmaceutical research and manufacturers of america perspective

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FCLPT.2013.170

Prediction of drug-drug interactions from in vitro induction data: application of the relative induction score approach using cryopreserved human hepatocytes

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FCLPT.2013.170

A combined model for predicting CYP3A4 clinical net drug-drug interaction based on CYP3A4 inhibition, inactivation, and induction determined in vitro

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FCLPT.2013.170

Evaluation of models for predicting drug-drug interactions due to induction

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FCLPT.2013.170

HepaRG cells as an in vitro model for evaluation of cytochrome P450 induction in humans

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FCLPT.2013.170

The quantitative prediction of in vivo enzyme-induction caused by drug exposure from in vitro information on human hepatocytes

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FCLPT.2013.170

Use of immortalized human hepatocytes to predict the magnitude of clinical drug-drug interactions caused by CYP3A4 induction

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FCLPT.2013.170

Modeling, prediction, and in vitro in vivo correlation of CYP3A4 induction

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FCLPT.2013.170

Towards a quantitative framework for the prediction of DDIs arising from cytochrome P450 induction

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FCLPT.2013.170

Evaluation of human liver slices and reporter gene assays as systems for predicting the cytochrome p450 induction potential of drugs in vivo in humans

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FCLPT.2013.170

Comparison of different algorithms for predicting clinical drug-drug interactions, based on the use of CYP3A4 in vitro data: predictions of compounds as precipitants of interaction

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FCLPT.2013.170

Monitoring plasma concentrations to individualize treatment with clomiphene citrate

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FCLPT.2013.170

The area under the plasma concentration-time curve for oral midazolam is 400-fold larger during treatment with itraconazole than with rifampicin.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FCLPT.2013.170

Pharmacokinetics of intravenous and oral midazolam in plasma and saliva in humans: usefulness of saliva as matrix for CYP3A phenotyping

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FCLPT.2013.170

Rifampin drastically reduces plasma concentrations and effects of oral midazolam.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FCLPT.2013.170

Intravenous and oral alfentanil as in vivo probes for hepatic and first-pass cytochrome P450 3A activity: noninvasive assessment by use of pupillary miosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FCLPT.2013.170

Assessing the clinical significance of botanical supplementation on human cytochrome P450 3A activity: comparison of a milk thistle and black cohosh product to rifampin and clarithromycin

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FCLPT.2013.170

Supplementation with goldenseal (Hydrastis canadensis), but not kava kava (Piper methysticum), inhibits human CYP3A activity in vivo.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FCLPT.2013.170

Comparison of midazolam and simvastatin as cytochrome P450 3A probes.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FCLPT.2013.170

Oxymorphone extended release does not affect CYP2C9 or CYP3A4 metabolic pathways

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FCLPT.2013.170

Concentrations and effects of oral midazolam are greatly reduced in patients treated with carbamazepine or phenytoin.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FCLPT.2013.170

Evidence of an interaction between nifedipine and nafcillin in humans

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FCLPT.2013.170

Duration of pleconaril effect on cytochrome P450 3A activity in healthy adults using the oral biomarker midazolam

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FCLPT.2013.170

Interactions between simvastatin and troglitazone or pioglitazone in healthy subjects

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FCLPT.2013.170

Effect of cimetidine or ranitidine administration on nifedipine pharmacokinetics and pharmacodynamics

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FCLPT.2013.170

The time to move cytochrome p450 induction into mainstream pharmacology is long overdue

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FCLPT.2013.170

7 January 2021

Mechanism-based inactivation of human cytochrome p450 enzymes and the prediction of drug-drug interactions

1 reference

https://api.crossref.org/works/10.1038%2FCLPT.2013.170

7 January 2021

Effect of carbamazepine on the single oral dose pharmacokinetics of alprazolam

1 reference

https://api.crossref.org/works/10.1038%2FCLPT.2013.170

7 January 2021

Influence of single- and multiple-dose omeprazole treatment on nifedipine pharmacokinetics and effects in healthy subjects

1 reference

https://api.crossref.org/works/10.1038%2FCLPT.2013.170

7 January 2021